Sai Life Sciences Limited
Max Life Insurance reduced its stake in Sai Life Sciences Limited from 1.63% to 1.54%, selling 1,73,373 shares.
A contract research and manufacturing organization serving the pharmaceutical and biotechnology industries, Sai Life Sciences conducts research activities and produces customized solutions for clients globally. Incorporated in 1999, the company operates as a specialized service provider, offering integrated capabilities across drug development, formulation, and manufacturing to support its customers' product pipelines and commercial operations in India and international markets.
Now branded Axis Max Life after Axis Bank took a controlling stake. Crossed Rs 1.5 lakh crore in AUM in April 2024 with over 20% YoY growth and has continued to compound. CIO Sachin Bajaj has over 25 years of investment experience and runs a multi-cap equity book across ULIP, par and non-par funds with a quality and growth tilt.